Hit enter to search or ESC to close
AsclepiX Therapeutics
Menu
  • About
    • Our Team
  • Technology
  • Pipeline
  • Media Center
    • News
    • Publications
  • Contact Us
    • About
      • Our Team
    • Technology
    • Pipeline
    • Media Center
      • News
      • Publications
    • Contact Us
    Daily Archives

    March 17, 2021

    News

    AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President

    Recent Posts

    • AsclepiX appoints Dr. Amir Shojaei as Chief Scientific Officer and Executive Vice President, Clinical Development
    • AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President
    • AsclepiX Therapeutics, Inc. Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for Diabetic Macular Edema (DME)
    • AsclepiX Therapeutics to Present at Solebury Trout Private Company Showcase on October 15, 2020
    • AsclepiX Therapeutics Announces $35 Million Series A Financing

    Recent Comments

      Asclepix Therapeutics Logo White

      Baltimore Office

      Corporate Headquarters
      301 W 29th Street, Suite 2004,
      Baltimore, Maryland 21211

      Contact Us

      © 2023 AsclepiX Therapeutics. All Rights Reserved. Privacy Policy | Terms of Use